Trial · NCT07892170
Effect of Vitamin D Supplementation Added to Iron Therapy in Children With Iron Deficiency Anemia
NCT07892170, Not applicable, Not yet recruiting, AlFayhaa General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Vitamin D Supplementation Added to Iron Therapy in Children With Iron Deficiency Anemia. Trials, record NCT07892170. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892170
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Vitamin D Supplementation Added to Iron Therapy in Children With Iron Deficiency Anemia
- NCT number
- NCT07892170
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 120 participants, estimated
- Lead sponsor
- AlFayhaa General Hospital
- Conditions
- Iron Deficiency Anemia
- Interventions
- Elemental iron, Vitamin D3 2000 IU/day, Vitamin D3 400 IU/day
- First posted
- 2026-10-23
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Between-Group Difference in Mean Change in Hemoglobin Concentration | Baseline to Week 12. | Change in hemoglobin concentration from baseline to Week 12, compared between the two randomized treatment groups. |
| Secondary | Change in Serum Ferritin | Baseline to Week 12. | Change in serum ferritin concentration from baseline to Week 12, compared between groups. |
| Secondary | Change in Serum 25-Hydroxyvitamin D. | Baseline to Week 12. | Change in serum 25(OH)D concentration from baseline to Week 12. |
| Secondary | Change in Mean Corpuscular Volume (MCV). | Baseline to Week 12. | Change in MCV from baseline to Week 12. |
| Secondary | Change in Mean Corpuscular Hemoglobin (MCH). | Baseline to Week 12. | Change in MCH from baseline to Week 12. |
| Secondary | Change in Serum Iron. Description | Baseline to Week 12. | Change in serum iron concentration from baseline to Week 12. Unit: µg/dL, if this is the laboratory's reporting unit. |
| Secondary | Change in Total Iron-Binding Capacity (TIBC). | Baseline to Week 12. | Change in TIBC from baseline to Week 12. Unit: Use the laboratory's reporting unit. |
| Secondary | Change in Serum Hepcidin. | Baseline to Week 12. | Change in serum hepcidin concentration from baseline to Week 12. Unit: Assay-dependent. |
| Secondary | Change in hsCRP. | Baseline to Week 12, subject to feasibility. | Change in hsCRP concentration from baseline to Week 12, if measured at both visits. |
| Secondary | Resolution of Anemia. | Week 12. | Proportion of participants meeting the prespecified hemoglobin criterion for anemia resolution at Week 12. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07892170
GET https://conductscience.org/api/trials/v1/NCT07892170/registered